Back to search

C3 Biotechnologies Limited

09620994

active
Private Limited Company
Companies House
Health Score
75 / 100

Some Concerns

25/30
Filing
10/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Current liabilities exceed current assets (-10)

Details

20 MANNIN WAY, LANCASTER, LA1 3SW
Incorporated 03/06/2015

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Michael Hyde Smith

director · Since 03/06/2015

DIRECTOR

BRITISH · UNITED KINGDOM · Age 68

Also on 5 other boards

Professor Nigel Scrutton

director · Since 12/08/2015

DIRECTOR

BRITISH · UNITED KINGDOM · Age 62

Also on 1 other board

Mr Phillip Dennison

secretary · Since 14/09/2022

Persons with Significant Control

Mr Michael Hyde Smith

Significant control

British · United Kingdom · Age 68

"La Croute De Bas",, Route De St. Andre,, St. Andrews,, GY6 8TX

Notified 25/04/2016

Professor Nigel Scrutton

25–50% shares
25–50% votes
right-to-appoint-and-remove-directors-as-firm

British · United Kingdom · Age 62

28 Chardin Avenue, Marple Bridge, SK6 5DN

Notified 04/06/2016

Mr Michael Hyde Smith

75–100% shares
75–100% votes
Appoint directors

British · United Kingdom · Age 68

"La Croute De Bas",, Route De St. Andre,, St. Andrews,, GY6 8TX

Notified 04/06/2016

Former PSCs

Professor Nigel Shaun Scrutton

Ceased 25/04/2016

CompanyRankvs 957+ SIC 72110 peers
67

Financial strength88th percentile among SIC peers · 22/25
Employees89th percentile among SIC peers · 13/15
LiquidityCurrent ratio 0.97× · 6/20
Longevity11 years trading (max 15) · 11/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
957C3 Biotechnologies Limited
63
How is this score calculated?
Financial strength22/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees13/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity6/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity11/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/09/2024

Net Worth

£442k

Balance sheet strength

Cash

£160k

Cash in the bank

Net Current Assets

-£8k

Working capital

Current Assets

£247k

Current Liabilities

£256k

Fixed Assets

£474k

Debtors

£87k

7avg. employees+2

Tax at Year End(2022)

Corp tax£30k

Director Loans(2019)

Company owes directors£14k

Balance Sheet

Intangible assets£400k
Assets less current liabilities£465k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20240.97-£148k
20232.35-£42k
20222.55+£722k
20200.29+£9k
20190.17-£80k
20180.76—

Derived from filed accounts. Not audited figures.